IN THIS ISSUE

Peter Wehrwein

Details may vary according to the characteristics of the providers, but there is a general framework

Focus on Biologics
Thomas Reinke

Some insurers and PBMs are experimenting with a pragmatic approach to covering testing

Biologics in Development
Editor’s Memo
John Marcille
Legislation & Regulation
John Carroll

Lora M. Pellegrini

A special panel hopes to push providers toward a global payment system that focuses more on outcomes

Evidence Review

A summary of ECRI Institute’s Emerging Technology Evidence Report

Medication Management
Thomas Reinke

Studies suggest that U.S. physicians are hesitant to put patients on insulin therapy, but these pens may offer value by improving control

Tomorrow’s Medicine
Thomas Morrow, MD

With a third oral therapy for multiple sclerosis, clinicians now have more choices to manage the devastating symptoms of the disease

News & Commentary
Frank Diamond
News & Commentary
News & Commentary
Frank Diamond
News & Commentary
Frank Diamond